Status:
UNKNOWN
Effects of Visual Biofeedback Therapy in Parkinson's Patients
Lead Sponsor:
Ziauddin University
Conditions:
Parkinson Disease
Eligibility:
All Genders
60-79 years
Phase:
NA
Brief Summary
Parkinson's disease (PD) affects approximately 6.5 million people around the world and it is ranked as the second most common age-related neurodegenerative disease after Alzheimer disease. US have rep...
Detailed Description
A total number of 36 patients will be recruited in the study. After the voluntary consent, all the patients will be randomly divided into Group A and B through the envelope method of simple random sam...
Eligibility Criteria
Inclusion
- Parkinson's disease of age between 60-79 years.
- Diagnosed PD stage III.
Exclusion
- Other neurological problems (Multiple sclerosis, amyotrophic lateral sclerosis and myasthenia gravis).
- Migraine.
- Auditory or visual deficits.
- Orthostatic hypotension.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 15 2022
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05325541
Start Date
March 1 2022
End Date
August 15 2022
Last Update
April 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziauddin University
Karachi, Sindh, Pakistan